University of Münster
CRIS@UM
DE | EN

Xenia Tran

No current affiliations available for this person. The person is no longer active at the university.

Publications

How to deliver an unselective drug selectively: Novel puromycin-loaded albumin nanoparticles for active targeting and their controllable effectiveness
Tran, Xenia; Mulac, Dennis; Langer, Klaus (2025)
In: Journal of Drug Delivery Science and Technology, 106. doi:10.1016/j.jddst.2025.106701
Research article (journal) | Peer reviewed | Published
Investigating the selectivity of the targeting properties of trastuzumab-bound nanoparticles to HER2/neu positive cells in co-culture
Tran, Xenia; Mulac, Dennis; Langer, Klaus (2024)
In: Journal of Drug Delivery Science and Technology, 100, 106040. doi:10.1016/j.jddst.2024.106040
Research article (journal) | Peer reviewed | Published
Investigating target selectivity of trastuzumab-bound nanoparticles in co-culture and spheroid cell models.
Tran, X.; Mulac, D.; Langer, K. (2024)
In: 14th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Wien, Austria. 
Poster | Peer reviewed | Published
Active targeting properties of trastuzumab-bound nanoparticles to HER2/neu-positive cells - now in 3D
Tran, X.; Mulac, D.; Langer, K. (2024)
In: DPhG Annual Meeting (2024), Münster, Germany. 
Poster | Peer reviewed | Published
More advanced cell culture models to investigate the selective targeting of trastuzumab-bound nanoparticles to HER2/neu-positive cells.
Tran, X.; Mulac, D.; Langer, K. (2023)
In: DPhG Annual Meeting, Tübingen, Germany. 
Abstract in digital collection (conference) | Peer reviewed | Published
Show all publications

Doctorates

Antikörper-modifizierte Nanopartikel zum spezifischen Targeting von Tumoren.
Candidate: Tran, Xenia | Supervisors: Langer, Prof. Dr. Klaus | Reviewers: Langer, Klaus; Düfer, Martina
Period of time: 01/05/2021 - 21/03/2025
Doctoral examination procedure finished at: Doctoral examination procedure at University of Münster